Patent
   D835258
Priority
Feb 22 2017
Filed
Feb 13 2018
Issued
Dec 04 2018
Expiry
Dec 04 2033
Assg.orig
Entity
unknown
6
27
n/a
The ornamental design for a pharmaceutical tablet, as shown and described.

FIG. 1 is a top perspective view of a pharmaceutical tablet in accordance with the present design;

FIG. 2 is a top plan view thereof;

FIG. 3 is a bottom plan view thereof;

FIG. 4 is a side elevational view thereof;

FIG. 5 is the opposite side elevational view thereof;

FIG. 6 is an end elevational view thereof;

FIG. 7 is the opposite end elevational view thereof;

FIG. 8 is a top perspective view of a pharmaceutical tablet in accordance with a second embodiment of the present design;

FIG. 9 is a top plan view thereof;

FIG. 10 is a bottom plan view thereof;

FIG. 11 is a side elevational view thereof;

FIG. 12 is the opposite side elevational view thereof;

FIG. 13 is an end elevational view thereof; and,

FIG. 14 is the opposite end elevational view thereof.

Portions of the tablet are shown in broken lines to indicate that those portions form no part of the claimed design.

Liu, Jiping, Parikh, Darshan, Burnside, Scott, Bhat, Sreenivas S.

Patent Priority Assignee Title
11279745, Apr 26 2019 Novo Nordisk A S Tolerogenic DNA vaccine
11466278, Nov 01 2016 Novo Nordisk A S Temperature based plasmid regulation system
D906513, Mar 19 2019 Novo Nordisk A S Pill
D907760, Jan 20 2017 SOCIÉTÉ DES PRODUITS NESTLÉ S A Orally ingestible tablet
D947358, Mar 19 2019 Novo Nordisk A/S Pill
ER3273,
Patent Priority Assignee Title
5770225, Apr 28 1989 McNeil-PPC, Inc. Process of preparing a subcoated simulated capsule-like medicament
5824338, Aug 19 1996 L. PERRIGO COMPANY Caplet and gelatin covering therefor
6165513, Jun 11 1997 Allergan Pharmaceuticals International Limited Film-coated tablet for improved upper gastrointestinal tract safety
D301764, Dec 21 1987 RHONE-POULENC RORER PHARMACEUTICALS INC Pharmaceutical tablet
D302051, Dec 21 1987 RHONE-POULENC RORER PHARMACEUTICALS INC Pharmaceutical tablet
31133,
D403396, Nov 28 1996 Astra Aktiebolag Tablet
D408910, Nov 28 1996 Astra Aktiebolag Tablet
D425614, Apr 16 1999 Merck Sharp & Dohme Corp Tablet
D430285, Apr 16 1999 MERCK & CO , INC Tablet
D431076, Jul 07 1999 Merck Sharp & Dohme Corp Tablet
D434846, Jul 07 1999 Merck Sharp & Dohme Corp Tablet
D459798, Mar 26 2001 AVENTIS PHARMA S A Pill tablet
D506544, Jan 13 2004 JOHNSON & JOHNSON CONSUMER INC Medicinal tablet
D515202, Jul 19 2004 Merck Sharp & Dohme Corp Tablet
D534646, Jan 06 2006 Access Business Group International LLC Nutritional supplement tablet
D535021, Apr 22 2005 WM WRIGLEY JR COMPANY Elliptical tablet
D564086, May 30 2005 Takeda Nycomed AS Tablet
D671636, Apr 23 2010 DAIICHI SANKYO COMPANY, LIMITED Pharmaceutical tablet
D735315, Jun 25 2012 Amgen Inc Pharmaceutical tablet
D741990, Jul 30 2013 RB HEALTH US LLC Tablet
D754841, Feb 03 2012 KENVUE BRANDS LLC Oral dosage form
D755949, Jul 30 2013 RB HEALTH US LLC Tablet
D771236, Dec 15 2015 KENVUE BRANDS LLC Tablet
D787042, Apr 28 2015 Celgene Corporation Pharmaceutical tablet
D787043, Jun 23 2015 Celgene Corporation Pharmaceutical tablet
D813372, Feb 22 2017 Celgene Corporation Pharmaceutical tablet
/
Executed onAssignorAssigneeConveyanceFrameReelDoc
Feb 13 2018Celgene Corporation(assignment on the face of the patent)
n/a
Date Maintenance Fee Events


n/a
Date Maintenance Schedule